Joe Zenkus, MS PT, MBA, is the Head of Business Development and Strategic Alliances at Sarepta Therapeutics. An accomplished biopharma leader with an established track record of value creation while undertaking expanding roles, Joe has executed on a wide range of deal types globally, from early discovery research collaborations to clinical / commercial stage M&A inclusive of Priority Review Voucher (“PRV”) monetization. Joe has led deals to multiple deals at SRPT involving sharing PRV economics with originators and monetizing PRV’s to pharma. Prior to joining Sarepta, Joe served as the Business Development Lead for Pfizer’s Rare Disease Business Unit. He previously held various leadership roles at Mylan in Corporate Development, Business Development, and Operations. Earlier in his career, he held sales roles at Schering-Plough / Merck. Joe earned an MBA in Finance from London Business School and an MS in Physical Therapy from the University of Massachusetts.